• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植后功能性自然杀伤细胞遗传学与微血管炎症:一项观察性队列研究

Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study.

作者信息

Diebold Matthias, Vietzen Hannes, Schatzl Martina, Mayer Katharina A, Haindl Susanne, Heinzel Andreas, Hittmeyer Philip, Herz Carsten T, Hopfer Helmut, Menter Thomas, Kühner Laura M, Berger Sarah M, Puchhammer-Stöckl Elisabeth, Doberer Konstantin, Steiger Jürg, Schaub Stefan, Böhmig Georg A

机构信息

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.

Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.

出版信息

Transplantation. 2025 May 1;109(5):860-870. doi: 10.1097/TP.0000000000005228. Epub 2025 Apr 17.

DOI:10.1097/TP.0000000000005228
PMID:39402708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12011434/
Abstract

BACKGROUND

Recent evidence highlights the pivotal role of natural killer (NK) cells in allograft rejection.

METHODS

We explored associations of missing self and gene polymorphisms determining the phenotype and/or functionality of NK cells with microvascular inflammation (MVI) in a single-center cohort of 507 consecutive kidney transplant recipients. Patients were genotyped for killer cell Ig-like receptors and polymorphisms in 4 selected genes ( FCGR3AV/F158 [rs396991], KLRC2wt/del , KLRK1HNK/LNK [rs1049174], and rs9916629-C/T).

RESULTS

MVI was detected in 69 patients (13.6%). In a proportional odds model, the KLRC2del/del variant reduced MVI risk (odds ratio [OR] 0.26; 95% confidence interval [CI], 0.05-0.93; P  = 0.037) independent of donor-specific antibodies, HLA class II eplet mismatch, and number of biopsies. Conversely, missing self (OR 1.40; 95% CI, 1.08-1.80; P  = 0.011) and the rs9916629 T/T gene variant increased the risk (OR 1.70; 95% CI, 1.08-2.68; P  = 0.021). Graft loss tended to be more frequent among patients with missing self ≥2 (hazard ratio 1.97; 95% CI, 0.89-4.37; P  = 0.097), without influence on estimated glomerular filtration trajectories. FCGR3A variants were associated with MVI only in patients with preformed and/or de novo donor-specific antibodies (OR 4.14; 95% CI, 0.99-17.47; P  = 0.052).

CONCLUSIONS

Missing self and NK-cell genetics may contribute to MVI, underscoring the important role of NK cells in transplant rejection.

摘要

背景

近期证据凸显了自然杀伤(NK)细胞在同种异体移植排斥反应中的关键作用。

方法

我们在一个由507例连续肾移植受者组成的单中心队列中,探究了“缺失自我”以及决定NK细胞表型和/或功能的基因多态性与微血管炎症(MVI)之间的关联。对患者进行杀伤细胞免疫球蛋白样受体以及4个选定基因(FCGR3AV/F158 [rs396991]、KLRC2wt/del、KLRK1HNK/LNK [rs1049174]和rs9916629-C/T)的多态性基因分型。

结果

69例患者(13.6%)检测到MVI。在比例优势模型中,KLRC2del/del变异降低了MVI风险(优势比[OR] 0.26;95%置信区间[CI],0.05 - 0.93;P = 0.037),独立于供体特异性抗体、HLA II类表位错配和活检次数。相反,“缺失自我”(OR 1.40;95% CI,1.08 - 1.80;P = 0.011)和rs9916629 T/T基因变异增加了风险(OR 1.70;95% CI,1.08 - 2.68;P = 0.021)。“缺失自我”≥2的患者中移植肾丢失往往更频繁(风险比1.97;95% CI,0.89 - 4.37;P = 0.097),对估计的肾小球滤过轨迹无影响。FCGR3A变异仅在有预先形成的和/或新发供体特异性抗体的患者中与MVI相关(OR 4.14;95% CI,0.99 - 17.47;P = 0.052)。

结论

“缺失自我”和NK细胞遗传学可能导致MVI,强调了NK细胞在移植排斥反应中的重要作用。

相似文献

1
Functional Natural Killer-cell Genetics and Microvascular Inflammation After Kidney Transplantation: An Observational Cohort Study.肾移植后功能性自然杀伤细胞遗传学与微血管炎症:一项观察性队列研究
Transplantation. 2025 May 1;109(5):860-870. doi: 10.1097/TP.0000000000005228. Epub 2025 Apr 17.
2
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.自然杀伤细胞功能遗传学与供者特异性抗体触发的微血管炎症。
Am J Transplant. 2024 May;24(5):743-754. doi: 10.1016/j.ajt.2023.12.005. Epub 2023 Dec 13.
3
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
4
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.抗抗体介导排斥的 Felzartamab 的随机 2 期试验。
N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25.
5
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
6
Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.缺失的自体诱导微血管排斥反应:一项基于人群的研究。
J Am Soc Nephrol. 2021 Aug;32(8):2070-2082. doi: 10.1681/ASN.2020111558. Epub 2021 Jul 22.
7
Microvascular inflammation in kidney allografts: New directions for patient management.肾移植受者微血管炎症:患者管理的新方向。
Am J Transplant. 2025 Jul;25(7):1410-1416. doi: 10.1016/j.ajt.2025.03.031. Epub 2025 Apr 6.
8
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
9
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.霉酚酸与硫唑嘌呤作为肾移植受者的初始免疫抑制治疗比较
Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2.
10
Immunosuppressive T-cell antibody induction for heart transplant recipients.心脏移植受者的免疫抑制性T细胞抗体诱导治疗
Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.

引用本文的文献

1
Sensitization in Transplantation Assessment of Risk 2025 innate working group: The potential role of innate allorecognition in kidney allograft damage.2025年移植风险评估中的固有免疫工作组:固有同种异体识别在肾移植损伤中的潜在作用。
Am J Transplant. 2025 Jul 5. doi: 10.1016/j.ajt.2025.06.030.
2
Targeting CD38 in Antibody-Mediated Rejection.在抗体介导的排斥反应中靶向CD38
Transpl Int. 2025 May 15;38:14343. doi: 10.3389/ti.2025.14343. eCollection 2025.
3
Antibody-mediated rejection-treatment standard.抗体介导的排斥反应治疗标准。

本文引用的文献

1
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.抗抗体介导排斥的 Felzartamab 的随机 2 期试验。
N Engl J Med. 2024 Jul 11;391(2):122-132. doi: 10.1056/NEJMoa2400763. Epub 2024 May 25.
2
Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation.自然杀伤细胞功能遗传学与供者特异性抗体触发的微血管炎症。
Am J Transplant. 2024 May;24(5):743-754. doi: 10.1016/j.ajt.2023.12.005. Epub 2023 Dec 13.
3
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.
Nephrol Dial Transplant. 2025 Aug 1;40(8):1615-1627. doi: 10.1093/ndt/gfaf097.
4
Follow-up biopsies with microvascular inflammation and persistent donor specific antibodies identify ongoing rejection in pediatric kidney transplant recipients.伴有微血管炎症和持续性供体特异性抗体的随访活检可识别小儿肾移植受者的持续性排斥反应。
Pediatr Nephrol. 2025 Jul;40(7):2375-2382. doi: 10.1007/s00467-025-06671-y. Epub 2025 Jan 28.
班夫 2022 年肾脏会议报告:重新评估微血管炎症和基于活检的转录诊断学的作用。
Am J Transplant. 2024 Mar;24(3):338-349. doi: 10.1016/j.ajt.2023.10.016. Epub 2023 Oct 28.
4
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection.对肾移植的转录和空间分析揭示了 FcyRIII+固有免疫细胞在排斥反应中的核心作用。
Nat Commun. 2023 Jul 19;14(1):4359. doi: 10.1038/s41467-023-39859-7.
5
Randomized Trial to Assess the Clinical Utility of Renal Allograft Monitoring by Urine CXCL10 Chemokine.随机临床试验评估尿液趋化因子 CXCL10 监测肾移植临床效用。
J Am Soc Nephrol. 2023 Aug 1;34(8):1456-1469. doi: 10.1681/ASN.0000000000000160. Epub 2023 May 25.
6
Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.无人类白细胞抗原供体特异性抗体和C4d情况下的微血管炎症:班夫分类中的一个孤立类别,伴有细胞毒性T细胞和自然杀伤细胞浸润。
Am J Transplant. 2023 Apr;23(4):464-474. doi: 10.1016/j.ajt.2022.12.018. Epub 2023 Jan 3.
7
The natural killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19.自然杀伤细胞相关的 rs9916629-C 等位基因是导致 COVID-19 患者死亡的新的遗传风险因素。
J Med Virol. 2023 Jan;95(1):e28404. doi: 10.1002/jmv.28404.
8
The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants.Fcγ 受体在抗体介导的肾移植排斥反应中的作用。
Transpl Int. 2022 Jul 20;35:10465. doi: 10.3389/ti.2022.10465. eCollection 2022.
9
Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: Differences in timing and intensity but similar mechanisms and outcomes.在肾移植活检中,有无供体特异性抗体的 ABMR 的分子诊断:时间和强度的差异,但机制和结果相似。
Am J Transplant. 2022 Aug;22(8):1976-1991. doi: 10.1111/ajt.17092. Epub 2022 Jun 2.
10
Deletion of the Natural Killer Cell Receptor NKG2C Encoding Gene and Kidney Transplant Outcome.自然杀伤细胞受体 NKG2C 编码基因缺失与肾移植结局。
Front Immunol. 2022 Mar 24;13:829228. doi: 10.3389/fimmu.2022.829228. eCollection 2022.